Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07506109
- Conditions
- BRAF V600E, Brain Diseases, Central Nervous System Diseases, +25 more
- Locations
-
- Peking union medical college hospital Beijing, Beijing Municipality, China
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
- West China Hospital Sichuan University Chengdu, Sichuan, China
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT07138755
- Conditions
- Adaptive Radiotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Xiangya 3rd Hospital, Central South University Changsha, Hunan, China
NCT07416890
- Conditions
- Central Nervous System Lymphoma, Pirtobrutinib, Sintilimab
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT07324824
- Conditions
- Adenocarcinoma, Bevacizimab, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT06714708
- Conditions
- Low Dose Radiotherapy, NSCLC, Neoadjuvant Immunotherapy, +1 more
- Locations
-
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
Recruiting
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
NCT06070636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT06413342
- Conditions
- Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +11 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT05707819
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
- Locations
-
- Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
Not Yet Recruiting
Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer
NCT06459921
- Conditions
- Locally Advanced Gastric Cancer, Neoadjuvant Chemotherapy, Sintilimab
- Locations
-
Not specified
NCT04271813
- Conditions
- Anlotinib, Chemo-free Therapy, Colonic Diseases, +14 more
- Locations
-
- Department of Medical Oncology, Shanghai Changzheng Hospital Shanghai, China
NCT04618367
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
NCT03936452
- Conditions
- Anlotinib, Early Stage, Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, +5 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
Active, Not Recruiting
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
NCT05400070
- Conditions
- Anlotinib, Chemotherapy, Lung Cancer, +8 more
- Locations
-
- Tangdu Hospital, the Air Force Military University Xi'an, China
Active, Not Recruiting
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
NCT06342167
- Conditions
- Concurrent Chemoradiotherapy, Immunonutrition, Locally Advanced Esophageal Squamous Cell Carcinoma, +2 more
- Locations
-
- Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China
- Department of Radiation Oncology，Clinical Oncology School of Fujian Medical University，Fujian Cancer Hospital Fujian, China
- Department of Oncology, Affiliated Hospital, Hebei University of Engineering Handan, Hebei, China
- Department 1st of Radiation Oncology, Anyang Tumor Hospital Anyang, Henan, China